Work

CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry

Year: 2018

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2018.10.015

Authors: Anneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, Jordi Doijen, Marta Arimont, Chunxia Zhao, Raimond Heukers, Rebecca Rimkunas, Chris de Graaf, Theo Verrips, Bas van der Woning, Hans de Haard, Joseph B. Rucker, Kurt Vermeire, Tracy Handel, Tom Van Loy, Martine J. Smit, Dominique Schols

Institutions: KU Leuven, Argenx (Belgium), Vrije Universiteit Amsterdam, University of California San Diego, Integral Molecular (United States)

Language: English

Topic: Chemokine receptors and signaling

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: European Commission, KU Leuven

Awards: ONCOgenic Receptor Network of Excellence and Training, G2692913314, G430449545, G434337789, G559573469

OpenAlex ID: W2896640337

FWCI: 1.967

Cites: 60

Cited by: 58

Related to: 10